Aankondiging • Jun 12
Global Compliance Applications Corp. announced that it expects to receive CAD 1.9 million in funding Global Compliance Applications Corp. announced a private placement to issue 190,000,000 shares at an issue price of CAD 0.01 per share for gross proceeds of up to CAD 1,900,000 on June 10, 2026. The private placement transaction is subject to the approval of the Canadian Securities Exchange. Upon closing, the shares will have a statutory 4 month and one day hold period. Finders' fees may be payable. Reported Earnings • Jun 02
Third quarter 2026 earnings released: CA$0.002 loss per share (vs CA$0.001 loss in 3Q 2025) Third quarter 2026 results: CA$0.002 loss per share (further deteriorated from CA$0.001 loss in 3Q 2025). Revenue: CA$4.2k (up 200% from 3Q 2025). Net loss: CA$894.6k (loss widened 109% from 3Q 2025). Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has fallen by 21% per year, which means it is significantly lagging earnings. New Risk • Apr 04
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 34% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (61% average weekly change). Negative equity (-CA$3.8m). Earnings have declined by 13% per year over the past 5 years. Shareholders have been substantially diluted in the past year (34% increase in shares outstanding). Revenue is less than US$1m (CA$16k revenue, or US$12k). Market cap is less than US$10m (CA$4.18m market cap, or US$3.00m). Aankondiging • Apr 01
Global Compliance Applications Corp. announced that it has received CAD 0.10303 million in funding On March 31, 2026, Global Compliance Applications Corp. has closed the transaction. Reported Earnings • Mar 02
Second quarter 2026 earnings released: EPS: CA$0 (vs CA$0 in 2Q 2025) Second quarter 2026 results: EPS: CA$0 (in line with 2Q 2025). Revenue: CA$5.1k (up CA$4.5k from 2Q 2025). Net loss: CA$172.8k (loss widened 98% from 2Q 2025). Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. New Risk • Feb 06
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 26% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$74k free cash flow). Negative equity (-CA$3.6m). Earnings have declined by 8.3% per year over the past 5 years. Revenue is less than US$1m (CA$12k revenue, or US$8.7k). Market cap is less than US$10m (CA$5.89m market cap, or US$4.32m). Minor Risk Shareholders have been diluted in the past year (26% increase in shares outstanding). Board Change • Jan 16
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Jeff Hayzlett was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Dec 21
Full year 2025 earnings released: CA$0.004 loss per share (vs CA$0.006 loss in FY 2024) Full year 2025 results: CA$0.004 loss per share (improved from CA$0.006 loss in FY 2024). Revenue: CA$7.0k (down 47% from FY 2024). Net loss: CA$1.23m (loss narrowed 17% from FY 2024). Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 21% per year, which means it is significantly lagging earnings. New Risk • Dec 17
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Negative equity (-CA$3.2m). Revenue is less than US$1m (CA$9.3k revenue, or US$6.8k). Market cap is less than US$10m (CA$1.78m market cap, or US$1.29m). Minor Risk Latest financial reports are more than 6 months old (reported March 2025 fiscal period end). Board Change • Aug 19
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 3 highly experienced directors. 1 independent director (2 non-independent directors). Independent Non-Executive Director Jeff Hayzlett was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Board Change • Jul 23
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 3 highly experienced directors. 1 independent director (2 non-independent directors). Independent Non-Executive Director Jeff Hayzlett was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. New Risk • Jun 08
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 25% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (56% average weekly change). Negative equity (-CA$3.2m). Revenue is less than US$1m (CA$9.3k revenue, or US$6.8k). Market cap is less than US$10m (CA$1.78m market cap, or US$1.30m). Minor Risk Shareholders have been diluted in the past year (25% increase in shares outstanding). Reported Earnings • Jun 02
Third quarter 2025 earnings released: CA$0.001 loss per share (vs CA$0.001 loss in 3Q 2024) Third quarter 2025 results: CA$0.001 loss per share (in line with 3Q 2024). Revenue: CA$1.4k (down 26% from 3Q 2024). Net loss: CA$428.9k (loss widened 32% from 3Q 2024). Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has fallen by 48% per year, which means it is significantly lagging earnings. Aankondiging • Apr 16
Global Compliance Applications Corp. announced that it has received CAD 0.08 million in funding On April 15, 2025 Global Compliance Applications Corp. closed the transaction. The company announced that it has issued 8,000,000 units of the Company at a price of CAD 0.01 per Unit for aggregate gross proceeds of CAD 80,000.. Each Unit consists of one common share in the capital of the Company and one Share purchase warrant. Each Warrant entitles the holder thereof to acquire one Share (at a price of CAD 0.05 per Warrant Share for a period of 36 months from the closing date of the Offering. All securities issued in the Offering are subject to a statutory hold period of four months and one day following the date of issuance in accordance with applicable Canadian securities laws. A finder’s fee of CAD 1,000 was paid to one finder. Reported Earnings • Mar 04
Second quarter 2025 earnings released: EPS: CA$0 (vs CA$0.001 loss in 2Q 2024) Second quarter 2025 results: EPS: CA$0 (improved from CA$0.001 loss in 2Q 2024). Revenue: CA$626 (down 74% from 2Q 2024). Net loss: CA$87.2k (loss narrowed 72% from 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has fallen by 53% per year, which means it is performing significantly worse than earnings. Reported Earnings • Dec 15
Full year 2024 earnings released: CA$0.006 loss per share (vs CA$0.01 loss in FY 2023) Full year 2024 results: CA$0.006 loss per share (improved from CA$0.01 loss in FY 2023). Revenue: CA$13.1k (up 57% from FY 2023). Net loss: CA$1.49m (loss narrowed 31% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 52% per year whereas the company’s share price has fallen by 54% per year. Aankondiging • Nov 14
Global Compliance Applications Corp. announced that it has received CAD 0.0765 million in funding On November 13, 2024, Global Compliance Applications Corp. closed the transaction. The transaction included participation from three investors. Aankondiging • Aug 27
Global Compliance Applications Corp. announced that it has received CAD 0.029 million in funding On August 26, 2024, Global Compliance Applications Corp., closed the transaction. Aankondiging • Aug 08
Global Compliance Applications Corp. announced that it has received $0.03394 million in funding On August 7, 2024, Global Compliance Applications Corp. closed the transaction. The transaction included participation from a single investor. Reported Earnings • Jun 04
Third quarter 2024 earnings released: CA$0.001 loss per share (vs CA$0.001 loss in 3Q 2023) Third quarter 2024 results: CA$0.001 loss per share (in line with 3Q 2023). Revenue: CA$1.9k (down 3.5% from 3Q 2023). Net loss: CA$325.0k (loss narrowed 1.0% from 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 51% per year whereas the company’s share price has fallen by 54% per year. Aankondiging • May 25
Global Compliance Applications Corp., Annual General Meeting, Jul 12, 2024 Global Compliance Applications Corp., Annual General Meeting, Jul 12, 2024. Location: british columbia, vancouver Canada Aankondiging • May 03
Global Compliance Applications Corp. announced that it has received CAD 0.01 million in funding On May 2, 2024, Global Compliance Applications Corp. closed the transaction. Aankondiging • Mar 15
Global Compliance Applications Corp. announced that it has received CAD 0.03 million in funding On March 14, 2024, Global Compliance Applications Corp., closed the transaction. Reported Earnings • Mar 03
Second quarter 2024 earnings released: CA$0.001 loss per share (vs CA$0.003 loss in 2Q 2023) Second quarter 2024 results: CA$0.001 loss per share (improved from CA$0.003 loss in 2Q 2023). Revenue: CA$2.4k (up 29% from 2Q 2023). Net loss: CA$308.0k (loss narrowed 44% from 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has fallen by 62% per year, which means it is performing significantly worse than earnings. Aankondiging • Feb 28
Global Compliance Applications Corp. announced that it expects to receive CAD 0.03 million in funding Global Compliance Applications Corp. announced a non-brokered private placement of 1,500,000 units at a price of CAD 0.02 per unit for the gross proceeds of CAD 30,000 on February 27, 2024. Each unit will consist of one common share in the capital of the company and one share purchase warrant. Each warrant will entitle the holder thereof to acquire one additional share at a price of CAD 0.05 per warrant share for a period of 24 months from the date of distribution. All securities issued in connection with the offering and will be subject to a statutory hold period of four months and one day following the date of issuance in accordance with applicable Canadian securities laws. Closing of the offering is expected to occur as soon as practicable and may occur in one or more tranches. Aankondiging • Dec 20
Global Compliance Applications Corp. announced that it has received CAD 0.064 million in funding On December 19, 2023, Global Compliance Applications Corp. closed the transaction. The company amended the terms of the transaction and announced that it has issued 2,133,333 units of the company at a price of CAD 0.03 per unit for the gross proceeds of CAD 64,000. Aankondiging • Dec 05
Global Compliance Applications Corp. announced that it expects to receive CAD 0.321675 million in funding Global Compliance Applications Corp. announced that it has completed a non-brokered private placement of 10,722,500 units at a price of CAD 0.03 per unit for gross proceeds of CAD 321,675 on December 4, 2023. Each unit will be composed of one common share in the capital of the company and one-half of one share purchase warrant. Each warrant will entitle the holder thereof to acquire one share at a price of CAD 0.065 per warrant share for a period of 24 months from the closing date of the offering. The offering may close on one or more dates as the company may determine. The company may pay a finder's fee in connection with the offering to eligible arm's-length finders in accordance with the policies of the Canadian Securities Exchange. All securities issued in connection with the offering and the debt settlement will be subject to a statutory hold period of four months and one day following the date of issuance in accordance with applicable Canadian securities laws. Reported Earnings • Nov 26
Full year 2023 earnings released: CA$0.01 loss per share (vs CA$0.011 loss in FY 2022) Full year 2023 results: CA$0.01 loss per share. Net loss: CA$2.17m (loss widened 3.4% from FY 2022). Reported Earnings • Jun 02
Third quarter 2023 earnings released: CA$0.001 loss per share (vs CA$0.002 loss in 3Q 2022) Third quarter 2023 results: CA$0.001 loss per share (improved from CA$0.002 loss in 3Q 2022). Net loss: CA$328.4k (loss narrowed 13% from 3Q 2022). Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has fallen by 31% per year, which means it is significantly lagging earnings. Reported Earnings • Mar 04
Second quarter 2023 earnings released: CA$0.003 loss per share (vs CA$0.003 loss in 2Q 2022) Second quarter 2023 results: CA$0.003 loss per share (in line with 2Q 2022). Net loss: CA$552.6k (loss widened 21% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 80% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings. Aankondiging • Jan 20
Global Compliance Applications Corp., Annual General Meeting, Mar 14, 2023 Global Compliance Applications Corp., Annual General Meeting, Mar 14, 2023. Aankondiging • Jan 05
Global Compliance Applications Corp. announced a financing transaction Global Compliance Applications Corp. announced a non-brokered private placement of units and common shares on January 3, 2022.
On the same date, the company has issued 7,788,727 units at a price of CAD 0.022 per unit for gross proceeds of CAD 171,352 in its first tranche. Each unit consists of one share and one share purchase warrant, whereby each warrant entitles the holder to purchase one additional share for a period of twenty-four months from closing at an exercise price of CAD 0.05 per share. All securities issued in connection with the first tranche are subject to a statutory hold period expiring four months and one day from the date of issuance of the securities. No finder’s fees were paid in connection with the first tranche. Reported Earnings • Dec 01
First quarter 2023 earnings released: CA$0.002 loss per share (vs CA$0.003 loss in 1Q 2022) First quarter 2023 results: CA$0.002 loss per share. Net loss: CA$466.1k (loss widened 18% from 1Q 2022). Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Jeff Hayzlett was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Aankondiging • Aug 16
Global Compliance Applications Corp. announced that it has received CAD 0.09 million in funding Global Cannabis Applications Corp. announced a non-brokered private placement of 2,250,000 units at a price of CAD 0.04 per unit for gross proceeds of CAD 90,000 on August 15, 2022. Each unit consists of a share and one share purchase warrant, whereby each warrant entitles the holder to purchase one additional share for a period of 2 years from closing at an exercise price of CAD 0.05 per share. Securities issued are subject to a statutory hold period expiring four months and one day from the date of issuance of the securities, expiring on December 16, 2022. Aankondiging • Jul 09
Global Cannabis Applications Corp. (CNSX:APP) completed the acquisition of WasteTrakr Technologies Inc. Global Cannabis Applications Corp. (CNSX:APP) entered into a definitive agreement to acquire WasteTrakr Technologies Inc. on June 16, 2022. As part of the consideration, Global Cannabis will issue an aggregate of 2,566,800 common shares in the capital of the company to the WTT shareholders pro rata in proportion to their holdings of the WTT shares and grant an aggregate of 500,000 common shares purchase warrants to WTT shareholders pro rata in proportion to their holdings of the WTT shares. Each consideration warrant will be exercisable into one common share in the capital of the company at a price of $0.09 per warrant share for a period of 24 month from the closing of the transaction. 10% of the consideration shares will be held back as security for the warranties, representations and covenants of WTT and WTT shareholders provided in the agreement. The transaction is subject to certain closing conditions including, without limitation, the receipt of all required regulatory and third-party approvals.
Global Cannabis Applications Corp. (CNSX:APP) completed the acquisition of WasteTrakr Technologies Inc. on July 8, 2022. Aankondiging • Jun 17
Global Cannabis Applications Corp. (CNSX:APP) entered into a definitive agreement to acquire WasteTrakr Technologies Inc. Global Cannabis Applications Corp. (CNSX:APP) entered into a definitive agreement to acquire WasteTrakr Technologies Inc. on June 16, 2022. As part of the consideration, Global Cannabis will issue an aggregate of 2,566,800 common shares in the capital of the company to the WTT shareholders pro rata in proportion to their holdings of the WTT shares and grant an aggregate of 500,000 common shares purchase warrants to WTT shareholders pro rata in proportion to their holdings of the WTT shares. Each consideration warrant will be exercisable into one common share in the capital of the company at a price of $0.09 per warrant share for a period of 24 month from the closing of the transaction. 10% of the consideration shares will be held back as security for the warranties, representations and covenants of WTT and WTT shareholders provided in the agreement. The transaction is subject to certain closing conditions including, without limitation, the receipt of all required regulatory and third-party approvals. Aankondiging • May 04
Global Cannabis Applications Corp. announced that it has received CAD 0.64 million in funding On May 2, 2022, Global Cannabis Applications Corp. closed the transaction. The company issued 9,400,000 units for gross proceeds of CAD 470,000 in its second and final tranche. The company has paid finder's fees of CAD 31,200 and issued 624,000 finder warrants, where the finder warrant has same terms as the warrant given in the unit. Securities issued are subject to a statutory hold period expiring four months and one day from the date of issuance of the securities.
The company has issued an aggregate of 12,800,000 units for gross proceeds of CAD 640,000. The company has paid finder's fees of CAD 38,400 and issued 768,000 finder warrants, where the finder warrant has same terms as the warrant given in the unit. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. 1 independent director (2 non-independent directors). Independent Non-Executive Director Jeff Hayzlett was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Aankondiging • Apr 07
Global Cannabis Applications Corp. announced a financing transaction Global Cannabis Applications Corp. announced a non-brokered private placement of units at a price of CAD 0.05 per unit on April 6, 2022. Each unit consists of a share and one share purchase warrant, whereby each warrant entitles the holder to purchase one additional share for a period of one year from closing at an exercise price of CAD 0.06 per share. Securities issued are subject to a statutory hold period expiring four months and one day from the date of issuance of the securities.
On the same date, the company issued 3,400,000 units for gross proceeds of CAD 170,000 in its first tranche. The company has paid finder's fees of CAD 7,200 and issued 144,000 finder warrants, where the finder warrant has same terms as the warrant given in the unit. Aankondiging • Jan 26
Global Cannabis Applications Corp. (CNSX:APP) entered into a letter of intent to acquire a 33% stake in Cell Captive from Blue Anchor Risk Solutions for CAD 0.76 million. Global Cannabis Applications Corp. (CNSX:APP) entered into a letter of intent to acquire a 33% stake in Cell Captive from Blue Anchor Risk Solutions for CAD 0.76 million on January 25, 2022. The consideration comprises of CAD 0.6 million in cash and 4 million common shares of GCAC. As part of the transaction, GCAC will grant BAR exclusive sub-license rights for Efixii software in South Africa, Lesotho and Zimbabwawe and BAR will pay GCAC royalties fees based on the usage. The transaction is subject to a definitive agreement no later than February 15, 2022. Aankondiging • Jan 12
Global Cannabis Applications Corp. Provides Update on Application for Medical Cannabis License Global Cannabis Applications Corp. provided an update October i, 2021, stating that all required information for its application for a Health Canada Medical Sales License under the Cannabis Act has been submitted and is currently in the review process. As announced GCAC plans to operate as a non-possession medical cannabis retailer that connects buyers to cultivators upon approval from Health Canada using a retail dropship model. As part of its new Non-Possession Medical Cannabis Sales business, GCAC will offer a Reddit-style Portal to medical cannabis consumers. Prescriptii, to review other users' cannabis experiences by helping consumers make informed cannabis choices by collating strain-to-pain reviews from 600,000 users across 9,000 strains in an intuitive, compliant Portal. Cultivators using Prescriptii will be required to utilize the company's track, trace and rate, Efixiifo] technology to ensure that customers are receiving guaranteed quality cannabis products. Cannabis-grows powered by Efixii generate truthful grow-data on an Ethereum blockchain. Prescriptii machine learning algorithms use Efixii grow and efficacy data to build strain-to-pain profiles, so that consumers can make informed choices. Furthermore, cultivators using Efixii can see what cannabis they should grow and also get reliable feedback for their strains. The Company confirms that its application for the non-possession medical cannabis sales license is still under review by Health Canada and will be granted upon successfully meeting all the requirements under the Cannabis Act. Aankondiging • May 07
Global Cannabis Applications Corp. announced that it has received CAD 0.538286 million in funding Global Cannabis Applications Corp. (CNSX:APP) announced a non brokered private placement of 2,760,439 units at a price of CAD 0.195 per unit for gross proceeds of CAD 538,285.61 on May 6, 2021. Each unit consists of one common share and one common share purchase warrant, whereby each warrant entitles the holder to purchase one additional common share for a period of two years from closing at an exercise price of CAD 0.26 per common share. All securities issued in connection are subject to a statutory hold period of four months from the date of issuance. The company paid finders' fees of CAD 9,104.55 and issued 14,000 finders' warrants in the transaction. Each finders' warrant bears the same terms as the warrants. Aankondiging • Feb 24
Global Cannabis Applications Corp. announced that it has received CAD 0.99467 million in funding On February 22, 2021, Global Cannabis Applications Corp. (CNSX:APP) closed the transaction. The company issued 6,184,490 units for gross proceeds of CAD 649,371.45. The company paid finder's fees in the amount of CAD 23,885.16, issued 44,755 finders' units, and 227,192 finder's warrants with each finders' unit having the same terms as the units issued in the transaction and each finder's warrant having the same terms as the warrants. Aankondiging • Feb 23
GCAC Announces $0.4m Deal with CBD Agrocasa Global Cannabis Applications Corp. announced it has signed a Memorandum of Understanding (“Agreement”) to supply Efixii QR Codes on the retail packaging of CBD Agrocasa. The Agreement is for the Efixii QR Codes to be applied to an initial retail rollout of 400 liters of CBD oil tinctures, containing approximately 2 million grams of cannabis, at a SaaS license cost of CA$0.20 per gram. GCAC’s Efixii platform attests to a CBD products’ lifecycle, from seed to sale, and is the only cannabis data platform in the world that then acquires actual user-efficacy data on CBD consumption using its Efixii app, now available on Apple’s App Store and Google’s Play Store. Subject to a successful collection of efficacy data in the initial 400 liter run, both parties agree to work in good faith to expand the commercial use of Efixii across Agrocasa’s harvests in the future. GCAC’s cannabis data is the intellectual property (“IP”) of GCAC. The IP creates an inherent difficulty in replicating, or directly competing with, GCAC’s medical cannabis datasets. GCAC defined their protocols in a provisional patent application, ‘System of Process and Tracking Cannabis Products and Associated Method Using Blockchain’ as filed with the U.S. Patent and Trademark Office on December 17, 2020. Is New 90 Day High Low • Feb 17
New 90-day high: CA$0.23 The company is up 292% from its price of CA$0.06 on 18 November 2020. The Canadian market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Healthcare Services industry, which is up 90% over the same period. Is New 90 Day High Low • Feb 11
New 90-day high: CA$0.23 The company is up 283% from its price of CA$0.06 on 12 November 2020. The Canadian market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Healthcare Services industry, which is up 65% over the same period. Aankondiging • Feb 05
Global Cannabis Applications Corp. announced a financing transaction Global Cannabis Applications Corp. (CNSX:APP) announced non-brokered private placement of units at a price of CAD 0.105 per unit on February 4, 2021. Each unit consists of one common share and one share purchase warrant exercisable at CAD 0.17 per share for a period of 3 years from closing. All securities issued are subject to a statutory hold period of four months from the date of issuance.
On the same date, the company has issued 3,288,561 units for gross proceeds of CAD 345,298.905 in its first tranche. The company has issued 223,919 finders' units with same terms. Aankondiging • Jan 09
Global Cannabis Applications Corp. announced that it has received CAD 0.42 million in funding Global Cannabis Applications Corp. (CNSX:APP) announced a non brokered private placement of 8,400,000 units at a price of CAD 0.05 per unit for gross proceeds of CAD 420,000 on January 8, 2021. Each unit consists of one common share and one common share purchase warrant, whereby each warrant entitles the holder to purchase one additional common share for a period of two years from closing at an exercise price of CAD 0.10 per common share. All securities issued in connection are subject to a statutory hold period of four months from the date of issuance. The company paid finders' fees of CAD 18,000 and issued 360,000 finders' warrants in the transaction. Each finders' warrant bears the same terms as the warrants. Aankondiging • Jan 05
Global Cannabis Applications Corp. Signs Citizen Green Efixii Reseller & License Agreement with Transparent-C Ltd Global Cannabis Applications Corp. announced it has signed a Citizen Green Efixii ("Efixii") Reseller & License Agreement ("Agreement") with Transparent-C Ltd. ("Transparent-C"). Following on from October's 3-year SaaS license sale of Efixii to the Israeli grower Bless Cultivation Ltd., GCAC continues to expand its international business development footprint with this Agreement. Transparent-C are now licensed to resell all GCAC SaaS products in Israel for a 20% revenue share of the cash received by GCAC, and at no upfront or recurring cost to GCAC. The nascent Israeli medical cannabis market is currently valued at $233 million annually, with more than 74,000 Israelis already having doctors' approval to medicate using cannabis. Efixii continues to generate significant interest amongst Israeli growers as a means to reduce the cost of both grow and export compliance, as well as being a complimentary technology for enhanced customer consumption monitoring, as required by Israeli law. Aankondiging • Dec 17
Global Cannabis Applications Corp. Announces Launch of Efixii Global Cannabis Applications Corp. announced the launch of Efixii, its medical cannabis efficacy consumer-app; continuing its focus on the benefits that efficacy-truths bring to the Canadian medical cannabis and adult-use markets, which are forecast to grow to CAD 4.1 billion in 20211. The new Efixii app provides numerous free services to consumers as well as premium subscription services. Prices start at CAD 0.99 per month for a single, personalized cannabis efficacy report for a patient. Prices increase for medical cannabis efficacy trend analyses or AI-driven product guidance based on a patient's symptoms. All in-app premium reports are based on the Efixii lifecycle-data that the GCAC platform acquired from cultivators, labs. and consumers. To bring medical cannabis consumption to the next level, GCAC delivers a suite of seed to sale cannabis lifecycle attestation technologies. The new Efixii app is a consumer view leveraging GCAC's proprietary big-data set. Valuable lifecycle details such as mother plant genomic sequence, and advanced batch-to-batch comparisons, serve to enhance medical cannabis reproducibility and deliver trustworthy efficacy results that patients can rely on when deciding to medicate with cannabis. All Efixii medical cannabis efficacy contributions remain the intellectual property ("IP") of GCAC. Securing GCAC's IP creates an inherent difficulty in replicating, or directly competing with, GCAC's medical cannabis datasets and technology solutions. The company believes this makes GCAC one of the most complete and exciting efficacy platforms in the cannabis space. Aankondiging • Nov 11
Global Cannabis Applications Corp. Enters into Definitive Agreement with Purity-IQ Biotechnology Global Cannabis Applications Corp. announced that it has signed a Definitive Agreement ("Agreement") with Canadian company Purity-IQ Inc. ("Purity-IQ") to commercially integrate the Purity-IQ Cannabis Authenticity and Purity Standard (CAPS) into the GCAC platform; with a focus on the Canadian medical cannabis and adult-use markets, which are forecast to grow to CAD 4.1 billion in 2021. This Agreement expands the GCAC Cultivator-SaaS license to allow cultivators to pay a "Purity-IQ Access Fee" to GCAC. The access fee enables the immutable connection of a medical cannabis strain' batch to a Purity-IQ ISO17025 certified laboratory test result. These results are then further attested-to using GCAC's chain of custody blockchain platform, thereby ensuring product quality and consistency of strain and dosage, for the consumer or patient. Aankondiging • Sep 29
Global Cannabis Applications Corp. announced that it has received CAD 0.017 million in funding Global Cannabis Applications Corp. (CNSX:APP) announced a non brokered private placement of 772,727 units at a price of CAD 0.022 per unit for gross proceeds of CAD 17,000 on September 28, 2020. Each unit consists of one common share and one common share purchase warrant, whereby each warrant entitles the holder to purchase one additional common share for a period of three years from closing at an exercise price of CAD 0.05 per common share. The transaction includes participation from directors and officers for 12,500,000 units. All securities issued in connection are subject to a statutory hold period of four months from the date of issuance. 
